Order Article Reprints

Tomas-Grau R, González-Lizárraga F, Ploper D, Avila CL, Socías SB, Besnault P, Tourville A, Mella RM, Villacé P, Salado C, et al. Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound. Cells. 2022; 11(17):2759. https://doi.org/10.3390/cells11172759

Tomas-Grau, Rodrigo, Florencia González-Lizárraga, Diego Ploper, César L. Avila, Sergio B. Socías, Pierre Besnault, Aurore Tourville, Rosa M. Mella, Patricia Villacé, Clarisa Salado, and et al. 2022. "Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound" Cells 11, no. 17: 2759. https://doi.org/10.3390/cells11172759

Tomas-Grau, R., González-Lizárraga, F., Ploper, D., Avila, C. L., Socías, S. B., Besnault, P., Tourville, A., Mella, R. M., Villacé, P., Salado, C., Rose, C., Seon-Méniel, B., Brunel, J.-M., Ferrié, L., Raisman-Vozari, R., Michel, P. P., Figadère, B., & Chehín, R. (2022). Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound. Cells, 11(17), 2759. https://doi.org/10.3390/cells11172759